Kevin O’Meara
Vice President, Patient Services
Expertise:
Kevin O’Meara is a patient services leader who is driving change for clients and their patients. With more than 25 years in executive-level leadership roles, he understands the complexities behind access barriers, copay programs and reimbursement, and patient onboarding, and how program challenges affect the patient journey. More specifically, his experience focused on managed care and commercial operations, including copay programs and patient access programs positioned to drive prescription growth. At EVERSANA, Kevin works with clients to pave a pathway for patients and providers to access new and innovative treatments.
Kevin has a bachelor’s degree and an MBA from the University of Notre Dame.
Articles by Kevin O’Meara
Sound Off on Interoperability – Leveraging Next-Gen Tech for Enhanced Electronic Benefit Verification and Prior Authorizations to Streamline Workflow
The theme of a recent panel at Access USA was “Technology: the Good, the Bad, and the Ugly.” While serving as an instrument for addressing challenges, technological progress can also introduce new complexities. Watch the recording of “Sound Off on Interoperability – Leveraging Next-Gen Tech for Enhanced Electronic Benefit Verification and Prior Authorizations to Streamline Workflow,” presented by Kevin O’Meara, Vice President, Patient Services, EVERSANA, and Joel White, President, Horizon Government Affairs Rashi Roy, Manager, CF Patient Support Operations, Vertex Guidance and Patient Support (GPS), and moderated by Melissa Beatty, Head of Patient Services, Data Aggregation and Channel Marketing. Topics covered in the discussion include: Examining the current roles of […]
Patient Assistance for Gene Therapies
EVERSANA’s experts Kevin O’Meara and Skyler Vise recently took the stage at Access USA to discuss patient services solutions for patient assistance programs (PAPs) supporting cell and gene therapies. During the session, the experts explore how PAPs help support patients in accessing and affording treatment, especially for high-cost therapies like cell and gene therapies. The discussion also emphasizes the need for collaborative approaches to patient services and support, with a focus on improving patient outcomes and ensuring access to life-changing therapies. Despite being crucial to the patient outcome, PAPs encounter numerous complexities and challenges. The experts suggest that these programs need to overcome four major hurdles: Limited funding: Patient assistance […]
Brand Planning – Fitting Financial and Copay Services into Existing Models
EVERSANA’s Kevin O’Meara, Vice President, Patient Services Solutions, and Chris Lagoerio, Director, Revenue Management, presented a session, “Brand Planning – Fitting Financial and Copay Services into Existing Models,” at Informa Connect’s Copay, Reimbursement and Access Congress. Session Summary Since the early 2000s copay programs have evolved, becoming increasingly complex and costly. This shift, coupled with the introduction of The Affordable Care Act and rise of high deductible health plans (HDHPs), triggered brands to place a new focus on gross-to-net (GTN) revenue. With an increased spotlight on copay and copay costs, brands have looked to combat accumulators and maximizers, optimize program offers, provide alternative payment methods, seek alternative contracting methods and […]
Navigating the Complexities of Patient Care with Digital and Human Touchpoints
Three Key Objectives Guide Program Development: Access, Affordability and Adherence Patients taking branded therapies to manage long-term health conditions are faced with a dizzying array of challenges, all of which can hinder access to medication, create affordability challenges and undermine long-term adherence objectives. State-of-the-art wraparound support programs must be devised to help patients and their caregivers overcome all of these logistical and administrative hurdles. When devising the most impactful support programs, pharmaceutical companies and their service provider partners must identify the right balance among all of the options: Technology-based solutions to both automate and streamline repetitive tasks, such as electronic benefit verification, patient enrollment into a product hub and co-pay […]
Realign Access Strategies to Overcome Challenges of Co-pay Assistance and Cost Sharing Trends
Kevin O’Meara, EVERSANA’s Vice President of Patient Services Solutions, joined Peter Avalos, National Reimbursement Director at Daiichi Sankyo, Inc., to discuss the current challenges impeding patient access and how to best optimize your co-pay programs using customized solutions and digital innovations.
The Patient Access Paradox: How the New CMS Rule Could Prioritize Drug Pricing Before Clinical Decision-Making
In January 2023, co-pay programs will be put to the test, consequently examining how well your brand can adapt to the Final Rule changes to meet patient and provider needs. Our recommendation: Don’t wait – start solutioning a patient-centric approach to access and affordability now.